| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4I3E5
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000725 | recombinational repair | 6 | 7 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
| GO:0006259 | DNA metabolic process | 4 | 7 |
| GO:0006281 | DNA repair | 5 | 7 |
| GO:0006310 | DNA recombination | 5 | 7 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
| GO:0006950 | response to stress | 2 | 7 |
| GO:0006974 | DNA damage response | 4 | 7 |
| GO:0008152 | metabolic process | 1 | 7 |
| GO:0009987 | cellular process | 1 | 7 |
| GO:0033554 | cellular response to stress | 3 | 7 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
| GO:0043170 | macromolecule metabolic process | 3 | 7 |
| GO:0044237 | cellular metabolic process | 2 | 7 |
| GO:0044238 | primary metabolic process | 2 | 7 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 7 |
| GO:0046483 | heterocycle metabolic process | 3 | 7 |
| GO:0050896 | response to stimulus | 1 | 7 |
| GO:0051716 | cellular response to stimulus | 2 | 7 |
| GO:0071704 | organic substance metabolic process | 2 | 7 |
| GO:0090304 | nucleic acid metabolic process | 4 | 7 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 245 | 249 | PF00656 | 0.631 |
| CLV_C14_Caspase3-7 | 48 | 52 | PF00656 | 0.309 |
| CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.636 |
| CLV_PCSK_PC1ET2_1 | 220 | 222 | PF00082 | 0.654 |
| CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.504 |
| CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.192 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.431 |
| DOC_PP2B_LxvP_1 | 113 | 116 | PF13499 | 0.324 |
| DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.727 |
| DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.731 |
| DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.601 |
| DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.309 |
| LIG_BRCT_BRCA1_1 | 229 | 233 | PF00533 | 0.586 |
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.328 |
| LIG_FHA_1 | 51 | 57 | PF00498 | 0.315 |
| LIG_FHA_1 | 79 | 85 | PF00498 | 0.384 |
| LIG_FHA_1 | 89 | 95 | PF00498 | 0.316 |
| LIG_FHA_2 | 178 | 184 | PF00498 | 0.589 |
| LIG_FHA_2 | 3 | 9 | PF00498 | 0.426 |
| LIG_FXI_DFP_1 | 181 | 185 | PF00024 | 0.501 |
| LIG_IRF3_LxIS_1 | 90 | 96 | PF10401 | 0.334 |
| LIG_LIR_Apic_2 | 189 | 194 | PF02991 | 0.541 |
| LIG_LIR_Gen_1 | 179 | 187 | PF02991 | 0.503 |
| LIG_LIR_Gen_1 | 62 | 71 | PF02991 | 0.309 |
| LIG_LIR_Nem_3 | 179 | 184 | PF02991 | 0.501 |
| LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.309 |
| LIG_LIR_Nem_3 | 72 | 78 | PF02991 | 0.309 |
| LIG_LYPXL_yS_3 | 75 | 78 | PF13949 | 0.309 |
| LIG_MYND_2 | 100 | 104 | PF01753 | 0.381 |
| LIG_NRBOX | 109 | 115 | PF00104 | 0.309 |
| LIG_SH2_CRK | 64 | 68 | PF00017 | 0.309 |
| LIG_SH2_STAP1 | 28 | 32 | PF00017 | 0.465 |
| LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.352 |
| LIG_SUMO_SIM_anti_2 | 242 | 248 | PF11976 | 0.534 |
| LIG_SUMO_SIM_anti_2 | 88 | 94 | PF11976 | 0.309 |
| LIG_SUMO_SIM_par_1 | 51 | 58 | PF11976 | 0.309 |
| LIG_SUMO_SIM_par_1 | 88 | 97 | PF11976 | 0.309 |
| LIG_WRC_WIRS_1 | 178 | 183 | PF05994 | 0.579 |
| MOD_CK1_1 | 157 | 163 | PF00069 | 0.724 |
| MOD_CK1_1 | 26 | 32 | PF00069 | 0.396 |
| MOD_CK2_1 | 187 | 193 | PF00069 | 0.543 |
| MOD_CK2_1 | 2 | 8 | PF00069 | 0.432 |
| MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.611 |
| MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.588 |
| MOD_GlcNHglycan | 155 | 159 | PF01048 | 0.621 |
| MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.632 |
| MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.624 |
| MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.398 |
| MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.309 |
| MOD_GlcNHglycan | 58 | 62 | PF01048 | 0.330 |
| MOD_GSK3_1 | 124 | 131 | PF00069 | 0.648 |
| MOD_GSK3_1 | 162 | 169 | PF00069 | 0.642 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.363 |
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.438 |
| MOD_GSK3_1 | 200 | 207 | PF00069 | 0.663 |
| MOD_GSK3_1 | 221 | 228 | PF00069 | 0.598 |
| MOD_GSK3_1 | 39 | 46 | PF00069 | 0.482 |
| MOD_N-GLC_1 | 225 | 230 | PF02516 | 0.605 |
| MOD_NEK2_1 | 93 | 98 | PF00069 | 0.309 |
| MOD_NEK2_2 | 59 | 64 | PF00069 | 0.309 |
| MOD_PK_1 | 212 | 218 | PF00069 | 0.557 |
| MOD_PKA_2 | 147 | 153 | PF00069 | 0.593 |
| MOD_Plk_1 | 50 | 56 | PF00069 | 0.299 |
| MOD_Plk_1 | 88 | 94 | PF00069 | 0.348 |
| MOD_Plk_2-3 | 2 | 8 | PF00069 | 0.432 |
| MOD_Plk_4 | 187 | 193 | PF00069 | 0.517 |
| MOD_Plk_4 | 2 | 8 | PF00069 | 0.464 |
| MOD_Plk_4 | 50 | 56 | PF00069 | 0.309 |
| TRG_DiLeu_BaEn_1 | 242 | 247 | PF01217 | 0.530 |
| TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.309 |
| TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.309 |
| TRG_Pf-PMV_PEXEL_1 | 206 | 211 | PF00026 | 0.591 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I1R0 | Leptomonas seymouri | 49% | 97% |
| A0A3S7X1B4 | Leishmania donovani | 99% | 100% |
| A4HGB1 | Leishmania braziliensis | 73% | 99% |
| E9AZN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| Q4Q8J9 | Leishmania major | 94% | 100% |